WDR5
Tag
Aug 29, 2022
Previously overlooked proteins are a potential source for a new class of cancer killing drugs
Feb 07, 2019
Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene
Feb 12, 2016
Open source cancer research
Dec 08, 2015
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Dec 08, 2015
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.